- Harvest One Cannabis (HVT) has announced a new LivRelief InfusedTM product, Extra Strength Transdermal CBD Cream
- The new LivRelief product will be available this spring at the Ontario Cannabis Store
- It contains 750 milligrams of CBD, three times the amount found in the company’s regular strength Transdermal CBD Cream
- Harvest One Cannabis Inc. is a Canadian global cannabis company servicing both the medical and recreational cannabis markets
- Harvest One Cannabis (HVT) opened trading at $0.055 per share
Harvest One Cannabis (HVT) has announced a new LivRelief InfusedTM product, Extra Strength Transdermal CBD Cream.
The new LivRelief product will be available this spring at the Ontario Cannabis Store (OCS) as part of Harvest One’s expansion into the infused topicals market.
LivRelief InfusedTM Extra Strength Transdermal CBD Cream contains 750 milligrams of CBD, three times the amount of cannabinoids found in the company’s regular strength Transdermal CBD Cream.
“Harvest One’s LivRelief InfusedTM Transdermal CBD Cream continues its momentum as the top selling SKU in the infused topicals category in Ontario,” commented Harvest One president and CEO Gord Davey.
“The company is excited to announce the expanded distribution of LivRelief InfusedTM Extra Strength Transdermal CBD Cream,” he added, remarking that “this is another key milestone for Harvest One as we continue to grow and add to our portfolio of infused licensed products.”
Harvest One remains committed to innovation and robust product development to ensure it continually meets the needs of the cannabis consumer base.
The company stated that it intends to further develop its licensed cannabis-infused topicals with plans of expanding its offerings in Canada and other global markets.
Harvest One Cannabis Inc. is a Canadian global cannabis company servicing both the medical and recreational cannabis markets.
Harvest One Cannabis (HVT) opened trading at $0.055 per share.
